Search results
Results from the WOW.Com Content Network
Sales limits (per customer): Daily sales limit—must not exceed 3.6 grams of pseudoephedrine base without regard to the number of transactions; 30-day (not monthly) sales limit—must not exceed 7.5 grams of pseudoephedrine base if sold by mail order or "mobile retail vendor" 30-day purchase limit—must not exceed 9 grams of pseudoephedrine base.
The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs: Retail provisions of the CMEA include daily sales limits and 30-day purchase ...
A person under the age of 18 who attempts to purchase a product that contains dextromethorphan, and uses false identification to do so, is subject to a $25 fine for the first offense, a $100 fine for the second offense, and a $200 for the third and each subsequent offense. This bill took effect March 19, 2015.
The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated. It was passed by the 91st United States Congress as Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970 and signed into ...
Illegal. As of 18 January 2007, [ 33 ] methamphetamine is classified as a Class A drug in the UK under the Misuse of Drugs Act 1971 following a recommendation made by the Advisory Council on the Misuse of Drugs in June 2006. [ 34 ] It had previously been classified as a Class B drug, except when prepared for injection.
Daily sales of regulated products not to exceed 3.6 g to a single purchaser, without regard to the number of transactions; Monthly sales to a single purchaser not to exceed 9 g of pseudoephedrine base in regulated products; The law gives similar regulations to mail-order purchases, except the monthly sales limit is 7.5 g.
The list is designated within the Controlled Substances Act [1] but can be modified by the U.S. Attorney General as illegal manufacturing practices change. Although the list is controlled by the Attorney General, the list is considered a DEA list because the DEA publishes and enforces the list.
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.